Rx Diet Drug – Q1 2013 Qsymia Sales Still Paltry
Qsymia sales for the first quarter were weighed down by continued reluctance of insurers to reimburse obesity treatments and the drug’s retail unavailability. Net product revenue, reflecting sales of Qsymia, doubled to $4.1 million from $2 million in the preceding quarter, but missed analysts’ estimate of $5.2 million. Despite the rising sales of the pill, […]
Rx Diet Drug – Q1 2013 Qsymia Sales Still Paltry Read More »